Evidence map›Paper›PMID 23426369›Full record

ArticleThe Journal of biological chemistry2013

Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages.

Katya B Rubinow, Valerie Z Wall, Joel Nelson, Daniel Mar, Karol Bomsztyk, Bardia Askari, Marvin A Lai, Kelly D Smith, Myoung Sook Han, Anuradha Vivekanandan-Giri and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 68 citations in OpenAlex.

  1. PLA2G16-Mediated Tetracosatetraenoic Acid Rewires Fatty Acid Oxidation to Impair CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel Insight Into the Role ofFrontiers in genetics · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Katya B RubinowDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109.
Valerie Z WallDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109.
Joel NelsonDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109.
Daniel MarDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109.
Karol BomsztykDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109.
Bardia AskariDiabetes and Obesity Center of Excellence, Departments of Pathology, University of Washington, Seattle, Washington 98109.
Marvin A LaiDiabetes and Obesity Center of Excellence, Departments of Pathology, University of Washington, Seattle, Washington 98109.
Kelly D SmithDiabetes and Obesity Center of Excellence, Departments of Pathology, University of Washington, Seattle, Washington 98109.
Myoung Sook HanProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Anuradha Vivekanandan-GiriDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109.
Subramaniam PennathurDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109.
Carolyn J AlbertDepartment of Biochemistry and Molecular Biology and Center for Cardiovascular Research, Saint Louis University School of Medicine, St. Louis, Missouri 63104.
David A FordDepartment of Biochemistry and Molecular Biology and Center for Cardiovascular Research, Saint Louis University School of Medicine, St. Louis, Missouri 63104.
Roger J DavisProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Karin E BornfeldtDiabetes and Obesity Center of Excellence, Departments of Medicine, University of Washington, Seattle, Washington 98109; Diabetes and Obesity Center of Excellence, Departments of Pathology, University of Washington, Seattle, Washington 98109. Electronic address: bornf@uw.edu.
University of Washington · USSaint Louis University · USUniversity of Massachusetts Chan Medical School · USUniversity of Michigan–Ann Arbor · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Spermatogonial Stem Cell Self-Renewal and DifferentiationU54HD042454 · NICHD · UNIVERSITY OF WASHINGTON · PI PAGE, STEPHANIE T · 2002 to 2016
$26.9M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI GOLDBERG, IRA J · 2008 to 2019
$23.5M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Integrated Systems Biology Approach to Diabetic Microvascular ComplicationsR24DK082841 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABCOUWER, STEVEN F, BROSIUS, FRANK C · 2008 to 2020
$13.1M
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
HYPERGLYCEMIA, PROTEIN KINASES AND SMOOTH MUSCLE GROWTHR01HL062887 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 1998 to 2014
$4.7M
Men's Reproductive Health Research at the Univ of WashingtonK12HD053984 · NICHD · UNIVERSITY OF WASHINGTON · PI BREMNER, WILLIAM J · 2006 to 2016
$2.9M
Plasmalogen-derived bioactive lipids in atherosclerosisR01HL074214 · NHLBI · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2004 to 2014
$2.8M
LAMININ GENE EXPRESSION IN GLOMERULAR CELLSR37DK045978 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2003 to 2011
$2.2M
NHLBI NIH HHS HL062887NHLBI NIH HHS HL074214NHLBI NIH HHS HL092969NHLBI NIH HHS HL111906NHLBI NIH HHS P01 HL092969NHLBI NIH HHS R01 HL062887NHLBI NIH HHS R01 HL074214NHLBI NIH HHS R01 HL097365NHLBI NIH HHS R21 HL111906NHLBI NIH HHS T32 HL007028NHLBI NIH HHS T32HL007312NIAID NIH HHS AI062859NIAID NIH HHS HHSN272200700038CNIAID NIH HHS R01 AI062859NICHD NIH HHS 6K12HD053984NICHD NIH HHS K12 HD053984NICHD NIH HHS U54 HD042454NIDDK NIH HHS DK017047NIDDK NIH HHS DK082841NIDDK NIH HHS DK083310NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK083310NIDDK NIH HHS R24 DK082841NIDDK NIH HHS R37 DK045978NIDDK NIH HHS R37 DK45978NIDDK NIH HHS T32 DK007247NIDDK NIH HHS T32DK007247
6 · The paper itself

Abstract

The enzyme acyl-CoA synthetase 1 (ACSL1) is induced by peroxisome proliferator-activated receptor α (PPARα) and PPARγ in insulin target tissues, such as skeletal muscle and adipose tissue, and plays an important role in β-oxidation in these tissues. In macrophages, however, ACSL1 mediates inflammatory effects without significant effects on β-oxidation. Thus, the function of ACSL1 varies in different tissues. We therefore investigated the signals and signal transduction pathways resulting in ACSL1 induction in macrophages as well as the consequences of ACSL1 deficiency for phospholipid turnover in LPS-activated macrophages. LPS, Gram-negative bacteria, IFN-γ, and TNFα all induce ACSL1 expression in macrophages, whereas PPAR agonists do not. LPS-induced ACSL1 expression is dependent on Toll-like receptor 4 (TLR4) and its adaptor protein TRIF (Toll-like receptor adaptor molecule 1) but does not require the MyD88 (myeloid differentiation primary response gene 88) arm of TLR4 signaling; nor does it require STAT1 (signal transducer and activator of transcription 1) for maximal induction. Furthermore, ACSL1 deletion attenuates phospholipid turnover in LPS-stimulated macrophages. Thus, the regulation and biological function of ACSL1 in macrophages differ markedly from that in insulin target tissues. These results suggest that ACSL1 may have an important role in the innate immune response. Further, these findings illustrate an interesting paradigm in which the same enzyme, ACSL1, confers distinct biological effects in different cell types, and these disparate functions are paralleled by differences in the pathways that regulate its expression.

Indexed as

AnimalsBone Marrow CellsCoenzyme A LigasesFemaleGram-Negative BacteriaImmunity, InnateInterferon-gammaLipopolysaccharidesMacrophagesMacrophages, PeritonealMaleMAP Kinase Kinase 4MiceMice, Inbred C57BLModels, BiologicalPhospholipidsACSL1 protein, mouseCoenzyme A LigasesInterferon-gammaLipopolysaccharidesMAP Kinase Kinase 4Phospholipids

Identifiers

PMID23426369
PMCPMC3617295
OpenAlexW1974581269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.